Schedule 13D ownership disclosure
ASCENDIS PHARMA A/S
Security class unavailable · CUSIP: 04351P101
Event date: 2016-10-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,229,514
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-129731
- Form type
- SC 13D
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- Oct 27, 2016
- Reporting period
- Oct 19, 2016
- Description
- Schedule 13D beneficial ownership